Progressive dystonia in a child with chromosome 18p deletion, treated with intrathecal baclofen

Journal of Child Neurology

Volumn 14, Issue 2, 1999, Pages 75-77

  Awaad, Yasser ^a   Munoz, Sharon ^a   Nigro, Michael ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACLOFEN;

ADOLESCENT; ANDROGEN INSENSITIVITY SYNDROME; APHASIA; APRAXIA; ARTICLE; AUTOSOMAL DOMINANT DISORDER; BODY POSTURE; CASE REPORT; CHOREA; CHROMOSOME 18; CHROMOSOME ANALYSIS; CHROMOSOME DELETION; DRUG EFFECT; DYSTONIA; FEMALE; HUMAN; INTRATHECAL DRUG ADMINISTRATION; INVOLUNTARY MOVEMENT; KARYOTYPE; PRIORITY JOURNAL;

EID: 0033007505     PISSN: 08830738     EISSN: None     Source Type: Journal    
DOI: 10.1177/088307389901400202     Document Type: Article

References (14)

1. Ozelius L, Bressman S, Kramer P, et al: Early-onset, generalized dystonia caused by DYT1 gene on chromosome 9q-34, in Segawa M, Nomura Y (eds): Age-Related Dopamine-Dependent Disorders. Monographs in Neural Science, vol 14. Basel, Karger, 1995, pp 126-132.
2. Wissel J, Poewe W: Dystonia: A clinical, neuropathological and therapeutic review. J Neurol Transm 1992;38(Suppl):91-104.
3. Fink JK, Hedera P, Mathay JG, Albin RL: Paroxysmal dystonic choreoathetosis linked to chromosome 2q: Clinical analysis and proposed pathophysiology. Neurology 1997;49:177-183.
4. De Grouchy J, Royer P, Lamy M: Deletion partielle des bras longs du chromosome 18. Pathol Biol 1964;12:579-582.
5. Gordon M, Bressman S, Brin M, et al: Dystonia in a patient with deletion of 18q. Mov Disord 1995;10:496-499.
6. Burke RE, Fahn S, Marsden CD, et al: Validity and reliability of rating scale for the primary tortion dystonias. Neurology 1985;35: 73-77.
7. Nygaard TG, Wilhelmsen KC, Risch NJ, et al: Linkage mapping of dopa-responsive dystonia (DRD) to chromosome 14q. Nat Genet 1993;5:386-391.
8. Kupke K, Graeber M, Müller U: Dystonia-parkinsonism syndrome (XPD) locus: Flanking markers in Xq12-q21.1. Am J Hum Genet 1992;50:808-815.
9. Wilhelmsen KC, Weeks DE, Nygaard TG, et al: Genetic mapping of 'lubag' (X-linked dystonia-parkinsonism) in a Filipino kindred to the pericentromeric region of the X chromosome. Ann Neurol 1991;29:124-131.
10. Kakinuma S, Sasabe F, Negoro K, et al: [18p-syndrome with bilateral pyramidal tract signs, dystonia of the lower extremities and concentric visual field defect]. Rinsho Shinkeigaku 1994;34: 474-478.
11. Greene PE, Fahn S: Baclofen in the treatment of idiopathic dystonia in children. Mov Disord 1992;7:48-52.
12. Paret G, Tirosh R, Ben Zeev B, et al: Intrathecal baclofen for severe torsion dystonia in a child. Acta Paediatr 1996;85:635-637.
13. Ford B, Geeen P, Louis E, et al: Use of Intrathecal Baclofen (ITB™) in the treatment of patients with dystonia. Arch Neurol 1996;53:1241-1246.
14. Albright LA, Barry MJ, Painter MJ, Shultz B: Infusion of intrathecal baclofen for generalized dystonia in cerebral palsy. J Neurol 1998;88:73-76.